The Lasting Benefit of Immune Checkpoint Inhibitors
Study suggests people with advanced lung cancer who have a sustained response to immunotherapy can safely stop treatment after two years.
Thanks to Lifesaving Cancer Research18,000,000cancer survivors in the United States are living with, through, and beyond their disease.
Your donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now